HRS-3095
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HRS-3095, covering 2025-12-03 to 2025-12-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Single and Multiple Doses of HRS-3095 Oral Administration in Healthy Subjects, as Well as the Effect of HRS-3095 on CYP3A4 Metabolic Enzymes [Phase 1]